A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

by | Nov 6, 2025 | Clinical Trials | 0 comments

​ Conditions: Hidradenitis Suppurativa

Interventions: Drug: SAR445399; Drug: Placebo

Sponsors: Sanofi

Not yet recruiting Conditions: Hidradenitis Suppurativa
Interventions: Drug: SAR445399; Drug: Placebo
Sponsors: Sanofi
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *